{"date":"2026-08-13","count":84,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-1795-2026-08-13-2123-xo2pc7","company_id":"1795","company":"美時","market":"上市","industry":"生技醫療","date":"2026-08-13","time":"21:23:00","subject":"公告本公司董事會決議辦理限制員工權利新股收回註銷減資事宜","clause":"第11款","fact_date":"2026-08-13","cite_as":"公開資訊觀測站重大訊息：美時（1795），2026-08-13 21:23，「公告本公司董事會決議辦理限制員工權利新股收回註銷減資事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1795-2026-08-13-2122-p2bfy9","company_id":"1795","company":"美時","market":"上市","industry":"生技醫療","date":"2026-08-13","time":"21:22:35","subject":"公告本公司訂定除權息基準日暨調整配股(息)率","clause":"第14款","fact_date":"2026-08-13","cite_as":"公開資訊觀測站重大訊息：美時（1795），2026-08-13 21:22，「公告本公司訂定除權息基準日暨調整配股(息)率」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1795-2026-08-13-2122-s729pi","company_id":"1795","company":"美時","market":"上市","industry":"生技醫療","date":"2026-08-13","time":"21:22:08","subject":"本公司取得新加坡子公司Lotus International Pte. Ltd.持有之Alvogen (Thailand) Ltd. 97.45%普通股股權","clause":"第20款","fact_date":"2026-08-13","cite_as":"公開資訊觀測站重大訊息：美時（1795），2026-08-13 21:22，「本公司取得新加坡子公司Lotus International Pte. Ltd.持有之Alvogen (Thailand」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1795-2026-08-13-2121-oq7ji3","company_id":"1795","company":"美時","market":"上市","industry":"生技醫療","date":"2026-08-13","time":"21:21:39","subject":"本公司董事會決議通過新加坡子公司處分Lotus Pharma Bulgaria EOOD股權案","clause":"第20款","fact_date":"2026-08-13","cite_as":"公開資訊觀測站重大訊息：美時（1795），2026-08-13 21:21，「本公司董事會決議通過新加坡子公司處分Lotus Pharma Bulgaria EOOD股權案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1795-2026-08-13-2114-1dqjnbf","company_id":"1795","company":"美時","market":"上市","industry":"生技醫療","date":"2026-08-13","time":"21:14:44","subject":"公告本公司董事會決議通過115年第二季財務報告","clause":"第31款","fact_date":"2026-08-13","cite_as":"公開資訊觀測站重大訊息：美時（1795），2026-08-13 21:14，「公告本公司董事會決議通過115年第二季財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4178-2026-08-13-2034-asq2d0","company_id":"4178","company":"永笙-KY","market":"上市","industry":"生技醫療","date":"2026-08-13","time":"20:34:11","subject":"公告本公司115年第2季合併財務報告董事會預計召開日期為115年08月21日","clause":"第31款","fact_date":"2026-08-13","cite_as":"公開資訊觀測站重大訊息：永笙-KY（4178），2026-08-13 20:34，「公告本公司115年第2季合併財務報告董事會預計召開日期為115年08月21日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6472-2026-08-13-2006-rqz2qw","company_id":"6472","company":"保瑞","market":"上市","industry":"生技醫療","date":"2026-08-13","time":"20:06:54","subject":"本公司董事會決議發行員工認股權憑證","clause":"第11款","fact_date":"2026-08-13","cite_as":"公開資訊觀測站重大訊息：保瑞（6472），2026-08-13 20:06，「本公司董事會決議發行員工認股權憑證」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4728-2026-08-13-2004-gx8nng","company_id":"4728","company":"雙美","market":"上櫃","industry":"生技醫療","date":"2026-08-13","time":"20:04:47","subject":"公告本公司董事會決議通過設立子公司。","clause":"第53款","fact_date":"2026-08-13","cite_as":"公開資訊觀測站重大訊息：雙美（4728），2026-08-13 20:04，「公告本公司董事會決議通過設立子公司。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4728-2026-08-13-2003-mpvz56","company_id":"4728","company":"雙美","market":"上櫃","industry":"生技醫療","date":"2026-08-13","time":"20:03:49","subject":"公告本公司執行副總經理異動。","clause":"第8款","fact_date":"2026-08-13","cite_as":"公開資訊觀測站重大訊息：雙美（4728），2026-08-13 20:03，「公告本公司執行副總經理異動。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6472-2026-08-13-2003-q13txb","company_id":"6472","company":"保瑞","market":"上市","industry":"生技醫療","date":"2026-08-13","time":"20:03:34","subject":"公告本公司第六屆薪資報酬委員會推舉召集人","clause":"第6款","fact_date":"2026-08-13","cite_as":"公開資訊觀測站重大訊息：保瑞（6472），2026-08-13 20:03，「公告本公司第六屆薪資報酬委員會推舉召集人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4728-2026-08-13-2002-1aqakd2","company_id":"4728","company":"雙美","market":"上櫃","industry":"生技醫療","date":"2026-08-13","time":"20:02:53","subject":"公告本公司執行長異動。","clause":"第8款","fact_date":"2026-08-13","cite_as":"公開資訊觀測站重大訊息：雙美（4728），2026-08-13 20:02，「公告本公司執行長異動。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6472-2026-08-13-2002-c6ibsk","company_id":"6472","company":"保瑞","market":"上市","industry":"生技醫療","date":"2026-08-13","time":"20:02:27","subject":"公告本公司董事會通過設置永續長","clause":"第8款","fact_date":"2026-08-13","cite_as":"公開資訊觀測站重大訊息：保瑞（6472），2026-08-13 20:02，「公告本公司董事會通過設置永續長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4728-2026-08-13-2001-1fo3n0u","company_id":"4728","company":"雙美","market":"上櫃","industry":"生技醫療","date":"2026-08-13","time":"20:01:53","subject":"公告本公司115年第二季財務報告業經提報董事會。","clause":"第31款","fact_date":"2026-08-13","cite_as":"公開資訊觀測站重大訊息：雙美（4728），2026-08-13 20:01，「公告本公司115年第二季財務報告業經提報董事會。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6472-2026-08-13-1959-f4zoc9","company_id":"6472","company":"保瑞","market":"上市","industry":"生技醫療","date":"2026-08-13","time":"19:59:11","subject":"董事會決議不分配115年上半年度盈餘","clause":"第14款","fact_date":"2026-08-13","cite_as":"公開資訊觀測站重大訊息：保瑞（6472），2026-08-13 19:59，「董事會決議不分配115年上半年度盈餘」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6472-2026-08-13-1955-1w4hqdc","company_id":"6472","company":"保瑞","market":"上市","industry":"生技醫療","date":"2026-08-13","time":"19:55:52","subject":"公告本公司董事會決議對子公司英屬維京群島Bora Global Ltd.現金增資案","clause":"第20款","fact_date":"2026-08-13","cite_as":"公開資訊觀測站重大訊息：保瑞（6472），2026-08-13 19:55，「公告本公司董事會決議對子公司英屬維京群島Bora Global Ltd.現金增資案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4129-2026-08-13-1939-1gx7b4o","company_id":"4129","company":"聯合","market":"上櫃","industry":"生技醫療","date":"2026-08-13","time":"19:39:47","subject":"公告更正本公司114年度中英文年報部分內容","clause":"第53款","fact_date":"2026-08-13","cite_as":"公開資訊觀測站重大訊息：聯合（4129），2026-08-13 19:39，「公告更正本公司114年度中英文年報部分內容」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4129-2026-08-13-1939-37n2dy","company_id":"4129","company":"聯合","market":"上櫃","industry":"生技醫療","date":"2026-08-13","time":"19:39:11","subject":"公告本公司董事會通過115年第二季合併財務報告","clause":"第31款","fact_date":"2026-08-13","cite_as":"公開資訊觀測站重大訊息：聯合（4129），2026-08-13 19:39，「公告本公司董事會通過115年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4129-2026-08-13-1937-isqttc","company_id":"4129","company":"聯合","market":"上櫃","industry":"生技醫療","date":"2026-08-13","time":"19:37:34","subject":"公告本公司董事會重要決議事項","clause":"第53款","fact_date":"2026-08-13","cite_as":"公開資訊觀測站重大訊息：聯合（4129），2026-08-13 19:37，「公告本公司董事會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6999-2026-08-13-1833-s3fqjw","company_id":"6999","company":"瀚醫生技","market":"興櫃","industry":"生技醫療","date":"2026-08-13","time":"18:33:01","subject":"公告本公司董事會決議通過115年第二季合併財務報告","clause":"第43款","fact_date":"2026-08-13","cite_as":"公開資訊觀測站重大訊息：瀚醫生技（6999），2026-08-13 18:33，「公告本公司董事會決議通過115年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4114-2026-08-13-1830-k5eu7n","company_id":"4114","company":"健喬","market":"上櫃","industry":"生技醫療","date":"2026-08-13","time":"18:30:36","subject":"公告本公司提報董事會115年度第2季合併財務報表","clause":"第31款","fact_date":"2026-08-13","cite_as":"公開資訊觀測站重大訊息：健喬（4114），2026-08-13 18:30，「公告本公司提報董事會115年度第2季合併財務報表」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6589-2026-08-13-1735-1chjvpv","company_id":"6589","company":"台康生技","market":"上市","industry":"生技醫療","date":"2026-08-13","time":"17:35:00","subject":"本公司授權夥伴 Sandoz 已向巴西國家衛生監督局(ANVISA)提交生物相似藥 EG12014 (trastuzumab biosimilar)150毫克凍晶注射劑劑型產品之上市許可申請","clause":"第10款","fact_date":"2026-08-13","cite_as":"公開資訊觀測站重大訊息：台康生技（6589），2026-08-13 17:35，「本公司授權夥伴 Sandoz 已向巴西國家衛生監督局(ANVISA)提交生物相似藥 EG12014 (trastuzum」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4744-2026-08-13-1717-1bv0034","company_id":"4744","company":"皇將","market":"上櫃","industry":"生技醫療","date":"2026-08-13","time":"17:17:05","subject":"公告本公司取消114年股東常會通過之私募有價證券案","clause":"第16款","fact_date":"2026-08-13","cite_as":"公開資訊觀測站重大訊息：皇將（4744），2026-08-13 17:17，「公告本公司取消114年股東常會通過之私募有價證券案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7871-2026-08-13-1715-6zb90s","company_id":"7871","company":"安立璽榮-KY","market":"興櫃","industry":"生技醫療","date":"2026-08-13","time":"17:15:04","subject":"公告本公司董事會通過115年第2季合併財務報告","clause":"第43款","fact_date":"2026-08-13","cite_as":"公開資訊觀測站重大訊息：安立璽榮-KY（7871），2026-08-13 17:15，「公告本公司董事會通過115年第2季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4744-2026-08-13-1713-z4sjer","company_id":"4744","company":"皇將","market":"上櫃","industry":"生技醫療","date":"2026-08-13","time":"17:13:22","subject":"本公司董事長林益裕先生向智慧財產及商業法院提起商業訴訟","clause":"第2款","fact_date":"2026-08-13","cite_as":"公開資訊觀測站重大訊息：皇將（4744），2026-08-13 17:13，「本公司董事長林益裕先生向智慧財產及商業法院提起商業訴訟」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7871-2026-08-13-1713-1aoweer","company_id":"7871","company":"安立璽榮-KY","market":"興櫃","industry":"生技醫療","date":"2026-08-13","time":"17:13:00","subject":"公告本公司董事會通過公司治理主管任命案","clause":"第11款","fact_date":"2026-08-13","cite_as":"公開資訊觀測站重大訊息：安立璽榮-KY（7871），2026-08-13 17:13，「公告本公司董事會通過公司治理主管任命案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6472-2026-08-13-1701-7i3bkn","company_id":"6472","company":"保瑞","market":"上市","industry":"生技醫療","date":"2026-08-13","time":"17:01:15","subject":"公告本公司董事會決議辦理收回限制員工權利新股註銷減資事宜","clause":"第11款","fact_date":"2026-08-13","cite_as":"公開資訊觀測站重大訊息：保瑞（6472），2026-08-13 17:01，「公告本公司董事會決議辦理收回限制員工權利新股註銷減資事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4744-2026-08-13-1659-1pbp993","company_id":"4744","company":"皇將","market":"上櫃","industry":"生技醫療","date":"2026-08-13","time":"16:59:50","subject":"代孫公司CVC Technologies Inc（USA）公告法人代表人及董事長異動","clause":"第6款","fact_date":"2026-08-13","cite_as":"公開資訊觀測站重大訊息：皇將（4744），2026-08-13 16:59，「代孫公司CVC Technologies Inc（USA）公告法人代表人及董事長異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6472-2026-08-13-1658-17up2wc","company_id":"6472","company":"保瑞","market":"上市","industry":"生技醫療","date":"2026-08-13","time":"16:58:56","subject":"公告本公司董事會決議員工認股權憑證轉換普通股之增資基準日","clause":"第11款","fact_date":"2026-08-13","cite_as":"公開資訊觀測站重大訊息：保瑞（6472），2026-08-13 16:58，「公告本公司董事會決議員工認股權憑證轉換普通股之增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4744-2026-08-13-1654-rgud9t","company_id":"4744","company":"皇將","market":"上櫃","industry":"生技醫療","date":"2026-08-13","time":"16:54:15","subject":"公告本公司董事會通過115年第二季合併財報","clause":"第31款","fact_date":"2026-08-13","cite_as":"公開資訊觀測站重大訊息：皇將（4744），2026-08-13 16:54，「公告本公司董事會通過115年第二季合併財報」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6704-2026-08-13-1648-1am22i4","company_id":"6704","company":"國璽幹細胞","market":"興櫃","industry":"生技醫療","date":"2026-08-13","time":"16:48:17","subject":"國璽幹細胞新藥思益優GXNPC1治療慢性腦中風第三期人體臨床試驗獲衛生福利部同意進行。","clause":"第44款","fact_date":"2026-08-13","cite_as":"公開資訊觀測站重大訊息：國璽幹細胞（6704），2026-08-13 16:48，「國璽幹細胞新藥思益優GXNPC1治療慢性腦中風第三期人體臨床試驗獲衛生福利部同意進行。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4155-2026-08-13-1633-1qkz1x4","company_id":"4155","company":"訊映","market":"上市","industry":"生技醫療","date":"2026-08-13","time":"16:33:04","subject":"代重要子公司PRODIGY DIABETES CARE, LLC.公告現金股利配發基準日","clause":"第14款","fact_date":"2026-08-13","cite_as":"公開資訊觀測站重大訊息：訊映（4155），2026-08-13 16:33，「代重要子公司PRODIGY DIABETES CARE, LLC.公告現金股利配發基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4155-2026-08-13-1632-124ffeh","company_id":"4155","company":"訊映","market":"上市","industry":"生技醫療","date":"2026-08-13","time":"16:32:45","subject":"代重要子公司PRODIGY DIABETES CARE, LLC.公告董事會決議發放現金股利","clause":"第14款","fact_date":"2026-08-13","cite_as":"公開資訊觀測站重大訊息：訊映（4155），2026-08-13 16:32，「代重要子公司PRODIGY DIABETES CARE, LLC.公告董事會決議發放現金股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3205-2026-08-13-1632-h4sav7","company_id":"3205","company":"佰研","market":"上櫃","industry":"生技醫療","date":"2026-08-13","time":"16:32:34","subject":"更正本公司115年7月資金貸與資訊揭露明細表","clause":"第53款","fact_date":"2026-08-13","cite_as":"公開資訊觀測站重大訊息：佰研（3205），2026-08-13 16:32，「更正本公司115年7月資金貸與資訊揭露明細表」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4155-2026-08-13-1632-ap96bl","company_id":"4155","company":"訊映","market":"上市","industry":"生技醫療","date":"2026-08-13","time":"16:32:14","subject":"公告本公司訂定現金減資基準日及調整減資比例","clause":"第11款","fact_date":"2026-08-13","cite_as":"公開資訊觀測站重大訊息：訊映（4155），2026-08-13 16:32，「公告本公司訂定現金減資基準日及調整減資比例」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6892-2026-08-13-1623-11mi7kj","company_id":"6892","company":"台寶生醫","market":"興櫃","industry":"生技醫療","date":"2026-08-13","time":"16:23:26","subject":"更正115年股東會議事錄部份資訊","clause":"第44款","fact_date":"2026-08-13","cite_as":"公開資訊觀測站重大訊息：台寶生醫（6892），2026-08-13 16:23，「更正115年股東會議事錄部份資訊」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6892-2026-08-13-1621-d6642k","company_id":"6892","company":"台寶生醫","market":"興櫃","industry":"生技醫療","date":"2026-08-13","time":"16:21:24","subject":"公告本公司董事會通過更換股務代理機構案","clause":"第44款","fact_date":"2026-08-13","cite_as":"公開資訊觀測站重大訊息：台寶生醫（6892），2026-08-13 16:21，「公告本公司董事會通過更換股務代理機構案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6467-2026-08-13-1620-17qvvm5","company_id":"6467","company":"泰合","market":"興櫃","industry":"生技醫療","date":"2026-08-13","time":"16:20:50","subject":"公告本公司董事會通過115年第二季財務報告","clause":"第43款","fact_date":"2026-08-13","cite_as":"公開資訊觀測站重大訊息：泰合（6467），2026-08-13 16:20，「公告本公司董事會通過115年第二季財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6892-2026-08-13-1620-37n2dy","company_id":"6892","company":"台寶生醫","market":"興櫃","industry":"生技醫療","date":"2026-08-13","time":"16:20:25","subject":"公告本公司董事會通過115年第二季合併財務報告","clause":"第43款","fact_date":"2026-08-13","cite_as":"公開資訊觀測站重大訊息：台寶生醫（6892），2026-08-13 16:20，「公告本公司董事會通過115年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6467-2026-08-13-1619-5rax5d","company_id":"6467","company":"泰合","market":"興櫃","industry":"生技醫療","date":"2026-08-13","time":"16:19:33","subject":"公告本公司董事會決議員工認股權憑證轉換普通股增資基準日","clause":"第9款","fact_date":"2026-08-13","cite_as":"公開資訊觀測站重大訊息：泰合（6467），2026-08-13 16:19，「公告本公司董事會決議員工認股權憑證轉換普通股增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4747-2026-08-13-1619-ohzkj7","company_id":"4747","company":"強生*","market":"上櫃","industry":"生技醫療","date":"2026-08-13","time":"16:19:20","subject":"公告本公司董事會決議自民國115年第三季起更換會計師事務所及簽證會計師","clause":"第7款","fact_date":"2026-08-13","cite_as":"公開資訊觀測站重大訊息：強生*（4747），2026-08-13 16:19，「公告本公司董事會決議自民國115年第三季起更換會計師事務所及簽證會計師」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6918-2026-08-13-1618-yniuci","company_id":"6918","company":"愛派司","market":"上市","industry":"生技醫療","date":"2026-08-13","time":"16:18:57","subject":"公告本公司董事會通過115年度第二季合併財務報告","clause":"第31款","fact_date":"2026-08-13","cite_as":"公開資訊觀測站重大訊息：愛派司（6918），2026-08-13 16:18，「公告本公司董事會通過115年度第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6864-2026-08-13-1613-kvn4qy","company_id":"6864","company":"元樟生技","market":"興櫃","industry":"生技醫療","date":"2026-08-13","time":"16:13:02","subject":"公告更正本公司115年上半年度IFRSs iXBRL財務報表附註部分資訊","clause":"第44款","fact_date":"2026-08-13","cite_as":"公開資訊觀測站重大訊息：元樟生技（6864），2026-08-13 16:13，「公告更正本公司115年上半年度IFRSs iXBRL財務報表附註部分資訊」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4747-2026-08-13-1611-s3fqjw","company_id":"4747","company":"強生*","market":"上櫃","industry":"生技醫療","date":"2026-08-13","time":"16:11:33","subject":"公告本公司董事會決議通過115年第二季合併財務報告","clause":"第31款","fact_date":"2026-08-13","cite_as":"公開資訊觀測站重大訊息：強生*（4747），2026-08-13 16:11，「公告本公司董事會決議通過115年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6696-2026-08-13-1607-1jw01z","company_id":"6696","company":"仁新*","market":"興櫃","industry":"生技醫療","date":"2026-08-13","time":"16:07:27","subject":"代重要子公司Belite Bio, Inc公告董事會決議通過現金增資子公司Belite Bio (HK) Limited","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：仁新*（6696），2026-08-13 16:07，「代重要子公司Belite Bio, Inc公告董事會決議通過現金增資子公司Belite Bio (HK) Limited」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6576-2026-08-13-1606-4g23j7","company_id":"6576","company":"逸達","market":"上櫃","industry":"生技醫療","date":"2026-08-13","time":"16:06:15","subject":"本公司董事會決議通過115年度第一次員工認股權憑證發行及認股辦法","clause":"第11款","fact_date":"2026-08-13","cite_as":"公開資訊觀測站重大訊息：逸達（6576），2026-08-13 16:06，「本公司董事會決議通過115年度第一次員工認股權憑證發行及認股辦法」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6696-2026-08-13-1605-1sp9mjr","company_id":"6696","company":"仁新*","market":"興櫃","industry":"生技醫療","date":"2026-08-13","time":"16:05:52","subject":"代重要子公司Belite Bio, Inc公告董事會決議通過現金增資子公司Belite Bio Holdings Corp.","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：仁新*（6696），2026-08-13 16:05，「代重要子公司Belite Bio, Inc公告董事會決議通過現金增資子公司Belite Bio Holdings Cor」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6576-2026-08-13-1604-p6ztc8","company_id":"6576","company":"逸達","market":"上櫃","industry":"生技醫療","date":"2026-08-13","time":"16:04:09","subject":"本公司董事會決議通過115年第2季合併財務報告","clause":"第31款","fact_date":"2026-08-13","cite_as":"公開資訊觀測站重大訊息：逸達（6576），2026-08-13 16:04，「本公司董事會決議通過115年第2季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7837-2026-08-13-1601-p67uuk","company_id":"7837","company":"啟新生","market":"興櫃","industry":"生技醫療","date":"2026-08-13","time":"16:01:09","subject":"公告本公司內部稽核主管異動","clause":"第11款","fact_date":"2026-08-13","cite_as":"公開資訊觀測站重大訊息：啟新生（7837），2026-08-13 16:01，「公告本公司內部稽核主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7837-2026-08-13-1600-37n2dy","company_id":"7837","company":"啟新生","market":"興櫃","industry":"生技醫療","date":"2026-08-13","time":"16:00:19","subject":"公告本公司董事會通過115年第二季合併財務報告","clause":"第43款","fact_date":"2026-08-13","cite_as":"公開資訊觀測站重大訊息：啟新生（7837），2026-08-13 16:00，「公告本公司董事會通過115年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4115-2026-08-13-1551-k8b0zn","company_id":"4115","company":"善德生技","market":"興櫃","industry":"生技醫療","date":"2026-08-13","time":"15:51:51","subject":"代重要子公司江蘇松德生物科技有限公司公告盈餘轉增資案","clause":"第9款","fact_date":"2026-08-13","cite_as":"公開資訊觀測站重大訊息：善德生技（4115），2026-08-13 15:51，「代重要子公司江蘇松德生物科技有限公司公告盈餘轉增資案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6586-2026-08-13-1550-1aoweer","company_id":"6586","company":"醣基","market":"興櫃","industry":"生技醫療","date":"2026-08-13","time":"15:50:34","subject":"公告本公司董事會通過公司治理主管任命案","clause":"第11款","fact_date":"2026-08-13","cite_as":"公開資訊觀測站重大訊息：醣基（6586），2026-08-13 15:50，「公告本公司董事會通過公司治理主管任命案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6586-2026-08-13-1550-14r86ev","company_id":"6586","company":"醣基","market":"興櫃","industry":"生技醫療","date":"2026-08-13","time":"15:50:15","subject":"公告本公司董事會通過稽核主管任命案","clause":"第11款","fact_date":"2026-08-13","cite_as":"公開資訊觀測站重大訊息：醣基（6586），2026-08-13 15:50，「公告本公司董事會通過稽核主管任命案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6586-2026-08-13-1549-vwb8j4","company_id":"6586","company":"醣基","market":"興櫃","industry":"生技醫療","date":"2026-08-13","time":"15:49:56","subject":"公告本公司董事會通過會計主管異動案","clause":"第11款","fact_date":"2026-08-13","cite_as":"公開資訊觀測站重大訊息：醣基（6586），2026-08-13 15:49，「公告本公司董事會通過會計主管異動案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4115-2026-08-13-1549-17bz8mt","company_id":"4115","company":"善德生技","market":"興櫃","industry":"生技醫療","date":"2026-08-13","time":"15:49:40","subject":"本公司依公開發行公司資金貸與及背書保證處理準則第二十五條第一項第四款規定公告","clause":"第19款","fact_date":"2026-08-13","cite_as":"公開資訊觀測站重大訊息：善德生技（4115），2026-08-13 15:49，「本公司依公開發行公司資金貸與及背書保證處理準則第二十五條第一項第四款規定公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6586-2026-08-13-1549-8rl2vz","company_id":"6586","company":"醣基","market":"興櫃","industry":"生技醫療","date":"2026-08-13","time":"15:49:38","subject":"公告本公司董事會通過財務主管異動案","clause":"第11款","fact_date":"2026-08-13","cite_as":"公開資訊觀測站重大訊息：醣基（6586），2026-08-13 15:49，「公告本公司董事會通過財務主管異動案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6586-2026-08-13-1548-1c75zvj","company_id":"6586","company":"醣基","market":"興櫃","industry":"生技醫療","date":"2026-08-13","time":"15:48:28","subject":"公告本公司董事會決議115年第二季不分派股利","clause":"第31款","fact_date":"2026-08-13","cite_as":"公開資訊觀測站重大訊息：醣基（6586），2026-08-13 15:48，「公告本公司董事會決議115年第二季不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6586-2026-08-13-1548-1oriwsg","company_id":"6586","company":"醣基","market":"興櫃","industry":"生技醫療","date":"2026-08-13","time":"15:48:14","subject":"公告本公司董事會通過115年度第2季合併財務報告","clause":"第43款","fact_date":"2026-08-13","cite_as":"公開資訊觀測站重大訊息：醣基（6586），2026-08-13 15:48，「公告本公司董事會通過115年度第2季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6917-2026-08-13-1548-pdazp1","company_id":"6917","company":"竟天","market":"興櫃","industry":"生技醫療","date":"2026-08-13","time":"15:48:12","subject":"更正本公司115年第2季IFRSs iXBRL部分申報資訊","clause":"第44款","fact_date":"2026-08-13","cite_as":"公開資訊觀測站重大訊息：竟天（6917），2026-08-13 15:48，「更正本公司115年第2季IFRSs iXBRL部分申報資訊」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6872-2026-08-13-1545-7rzr08","company_id":"6872","company":"浩宇生醫","market":"上櫃","industry":"生技醫療","date":"2026-08-13","time":"15:45:54","subject":"公告本公司法人董事指派代表人","clause":"第6款","fact_date":"2026-08-13","cite_as":"公開資訊觀測站重大訊息：浩宇生醫（6872），2026-08-13 15:45，「公告本公司法人董事指派代表人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6472-2026-08-13-1535-37n2dy","company_id":"6472","company":"保瑞","market":"上市","industry":"生技醫療","date":"2026-08-13","time":"15:35:55","subject":"公告本公司董事會通過115年第二季合併財務報告","clause":"第31款","fact_date":"2026-08-13","cite_as":"公開資訊觀測站重大訊息：保瑞（6472），2026-08-13 15:35，「公告本公司董事會通過115年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6666-2026-08-13-1535-1x6pzpc","company_id":"6666","company":"羅麗芬-KY","market":"上市","industry":"生技醫療","date":"2026-08-13","time":"15:35:29","subject":"更正:代子公司嘉文麗（福建）化妝品限公司公告累積取得或處分理財產品","clause":"第20款","fact_date":"2026-08-13","cite_as":"公開資訊觀測站重大訊息：羅麗芬-KY（6666），2026-08-13 15:35，「更正:代子公司嘉文麗（福建）化妝品限公司公告累積取得或處分理財產品」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6572-2026-08-13-1533-yniuci","company_id":"6572","company":"博錸","market":"興櫃","industry":"生技醫療","date":"2026-08-13","time":"15:33:25","subject":"公告本公司董事會通過115年度第二季合併財務報告","clause":"第43款","fact_date":"2026-08-13","cite_as":"公開資訊觀測站重大訊息：博錸（6572），2026-08-13 15:33，「公告本公司董事會通過115年度第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4133-2026-08-13-1533-c6ibsk","company_id":"4133","company":"亞諾法","market":"上市","industry":"生技醫療","date":"2026-08-13","time":"15:33:23","subject":"公告本公司董事會通過設置永續長","clause":"第8款","fact_date":"2026-08-13","cite_as":"公開資訊觀測站重大訊息：亞諾法（4133），2026-08-13 15:33，「公告本公司董事會通過設置永續長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7851-2026-08-13-1533-sn763a","company_id":"7851","company":"慧康生技*-KY","market":"興櫃","industry":"生技醫療","date":"2026-08-13","time":"15:33:06","subject":"公告本公司董事會決議通過115年第2季合併財務報告","clause":"第43款","fact_date":"2026-08-13","cite_as":"公開資訊觀測站重大訊息：慧康生技*-KY（7851），2026-08-13 15:33，「公告本公司董事會決議通過115年第2季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6572-2026-08-13-1532-gz87nk","company_id":"6572","company":"博錸","market":"興櫃","industry":"生技醫療","date":"2026-08-13","time":"15:32:48","subject":"公告本公司董事會決議通過內部稽核主管任命案","clause":"第11款","fact_date":"2026-08-13","cite_as":"公開資訊觀測站重大訊息：博錸（6572），2026-08-13 15:32，「公告本公司董事會決議通過內部稽核主管任命案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7851-2026-08-13-1532-1yafbfp","company_id":"7851","company":"慧康生技*-KY","market":"興櫃","industry":"生技醫療","date":"2026-08-13","time":"15:32:36","subject":"公告派任本公司資訊安全長","clause":"第11款","fact_date":"2026-08-13","cite_as":"公開資訊觀測站重大訊息：慧康生技*-KY（7851），2026-08-13 15:32，「公告派任本公司資訊安全長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7851-2026-08-13-1531-15s8s21","company_id":"7851","company":"慧康生技*-KY","market":"興櫃","industry":"生技醫療","date":"2026-08-13","time":"15:31:57","subject":"公告派任本公司公司治理主管","clause":"第11款","fact_date":"2026-08-13","cite_as":"公開資訊觀測站重大訊息：慧康生技*-KY（7851），2026-08-13 15:31，「公告派任本公司公司治理主管」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7851-2026-08-13-1530-129kdkl","company_id":"7851","company":"慧康生技*-KY","market":"興櫃","industry":"生技醫療","date":"2026-08-13","time":"15:30:22","subject":"本公司依「公開發行公司資金貸與及背書保證處理準則」第二十二條第一項第二款及第三款之規定辦理公告","clause":"第20款","fact_date":"2026-08-13","cite_as":"公開資訊觀測站重大訊息：慧康生技*-KY（7851），2026-08-13 15:30，「本公司依「公開發行公司資金貸與及背書保證處理準則」第二十二條第一項第二款及第三款之規定辦理公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4115-2026-08-13-1530-37n2dy","company_id":"4115","company":"善德生技","market":"興櫃","industry":"生技醫療","date":"2026-08-13","time":"15:30:21","subject":"公告本公司董事會通過115年第二季合併財務報告","clause":"第43款","fact_date":"2026-08-13","cite_as":"公開資訊觀測站重大訊息：善德生技（4115），2026-08-13 15:30，「公告本公司董事會通過115年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4137-2026-08-13-1528-1b9r7vd","company_id":"4137","company":"麗豐-KY","market":"上市","industry":"生技醫療","date":"2026-08-13","time":"15:28:34","subject":"公告本公司115年第二季合併財務報告董事會召開日期","clause":"第31款","fact_date":"2026-08-13","cite_as":"公開資訊觀測站重大訊息：麗豐-KY（4137），2026-08-13 15:28，「公告本公司115年第二季合併財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4133-2026-08-13-1526-6zb90s","company_id":"4133","company":"亞諾法","market":"上市","industry":"生技醫療","date":"2026-08-13","time":"15:26:50","subject":"公告本公司董事會通過115年第2季合併財務報告","clause":"第31款","fact_date":"2026-08-13","cite_as":"公開資訊觀測站重大訊息：亞諾法（4133），2026-08-13 15:26，「公告本公司董事會通過115年第2季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4746-2026-08-13-1512-5uwb2","company_id":"4746","company":"台耀","market":"上市","industry":"生技醫療","date":"2026-08-13","time":"15:12:49","subject":"本公司董事會通過115年度第2季合併財務報告","clause":"第31款","fact_date":"2026-08-13","cite_as":"公開資訊觀測站重大訊息：台耀（4746），2026-08-13 15:12，「本公司董事會通過115年度第2季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1707-2026-08-13-1511-s3fqjw","company_id":"1707","company":"葡萄王","market":"上市","industry":"生技醫療","date":"2026-08-13","time":"15:11:13","subject":"公告本公司董事會決議通過115年第二季合併財務報告","clause":"第31款","fact_date":"2026-08-13","cite_as":"公開資訊觀測站重大訊息：葡萄王（1707），2026-08-13 15:11，「公告本公司董事會決議通過115年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4746-2026-08-13-1510-ezubd","company_id":"4746","company":"台耀","market":"上市","industry":"生技醫療","date":"2026-08-13","time":"15:10:33","subject":"本公司董事會通過建置針劑廠自動化智能倉儲及GLP-1運輸系統","clause":"第15款","fact_date":"2026-08-13","cite_as":"公開資訊觀測站重大訊息：台耀（4746），2026-08-13 15:10，「本公司董事會通過建置針劑廠自動化智能倉儲及GLP-1運輸系統」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7790-2026-08-13-1510-yniuci","company_id":"7790","company":"思必瑞特","market":"興櫃","industry":"生技醫療","date":"2026-08-13","time":"15:10:29","subject":"公告本公司董事會通過115年度第二季合併財務報告","clause":"第43款","fact_date":"2026-08-13","cite_as":"公開資訊觀測站重大訊息：思必瑞特（7790），2026-08-13 15:10，「公告本公司董事會通過115年度第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6569-2026-08-13-1506-1biy3xk","company_id":"6569","company":"醫揚","market":"上櫃","industry":"生技醫療","date":"2026-08-13","time":"15:06:49","subject":"公告本公司115年度現金增資收足股款暨增資基準日","clause":"第53款","fact_date":"2026-08-13","cite_as":"公開資訊觀測站重大訊息：醫揚（6569），2026-08-13 15:06，「公告本公司115年度現金增資收足股款暨增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6666-2026-08-13-1455-16xx3hr","company_id":"6666","company":"羅麗芬-KY","market":"上市","industry":"生技醫療","date":"2026-08-13","time":"14:55:18","subject":"代子公司嘉文麗（福建）化妝品限公司公告累積取得或處分理財產品","clause":"第20款","fact_date":"2026-08-13","cite_as":"公開資訊觀測站重大訊息：羅麗芬-KY（6666），2026-08-13 14:55，「代子公司嘉文麗（福建）化妝品限公司公告累積取得或處分理財產品」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6782-2026-08-13-1438-xxbxjl","company_id":"6782","company":"視陽","market":"上市","industry":"生技醫療","date":"2026-08-13","time":"14:38:56","subject":"公告本公司受邀參加華南永昌證券舉辦之投資論壇","clause":"第12款","fact_date":"2026-08-21","cite_as":"公開資訊觀測站重大訊息：視陽（6782），2026-08-13 14:38，「公告本公司受邀參加華南永昌證券舉辦之投資論壇」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6712-2026-08-13-1418-1t5gay1","company_id":"6712","company":"長聖","market":"上櫃","industry":"生技醫療","date":"2026-08-13","time":"14:18:45","subject":"本公司受邀參加櫃買中心舉辦之業績發表會","clause":"第12款","fact_date":"2026-08-17","cite_as":"公開資訊觀測站重大訊息：長聖（6712），2026-08-13 14:18，「本公司受邀參加櫃買中心舉辦之業績發表會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4168-2026-08-13-1402-yniuci","company_id":"4168","company":"醣聯","market":"上櫃","industry":"生技醫療","date":"2026-08-13","time":"14:02:36","subject":"公告本公司董事會通過115年度第二季合併財務報告","clause":"第31款","fact_date":"2026-08-13","cite_as":"公開資訊觀測站重大訊息：醣聯（4168），2026-08-13 14:02，「公告本公司董事會通過115年度第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6541-2026-08-13-1401-54swv6","company_id":"6541","company":"泰福-KY","market":"上市","industry":"生技醫療","date":"2026-08-13","time":"14:01:32","subject":"公告本公司法人董事改派代表人","clause":"第6款","fact_date":"2026-08-13","cite_as":"公開資訊觀測站重大訊息：泰福-KY（6541），2026-08-13 14:01，「公告本公司法人董事改派代表人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4744-2026-08-13-1352-1vhu1xi","company_id":"4744","company":"皇將","market":"上櫃","industry":"生技醫療","date":"2026-08-13","time":"13:52:24","subject":"公告本公司發言人異動","clause":"第8款","fact_date":"2026-08-13","cite_as":"公開資訊觀測站重大訊息：皇將（4744），2026-08-13 13:52，「公告本公司發言人異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6934-2026-08-13-1345-1h148f4","company_id":"6934","company":"心誠鎂","market":"上市","industry":"生技醫療","date":"2026-08-13","time":"13:45:30","subject":"本公司董事會通過115年第二季合併財務報告","clause":"第31款","fact_date":"2026-08-13","cite_as":"公開資訊觀測站重大訊息：心誠鎂（6934），2026-08-13 13:45，「本公司董事會通過115年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6492-2026-08-13-1333-37n2dy","company_id":"6492","company":"生華科","market":"上櫃","industry":"生技醫療","date":"2026-08-13","time":"13:33:30","subject":"公告本公司董事會通過115年第二季合併財務報告","clause":"第31款","fact_date":"2026-08-13","cite_as":"公開資訊觀測站重大訊息：生華科（6492），2026-08-13 13:33，「公告本公司董事會通過115年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}